Skip to main content
. 2022 Apr 29;20(2):192–202. doi: 10.5217/ir.2020.00150

Fig. 1.

Fig. 1.

The prevalence of complementary and alternative medicine service (A) and product (B) usage among patients with inflammatory bowel disease from 3 countries. The P-value is for the analysis of variance and was adjusted for physicians’ age and sex and the hospital type. aP<0.05, bP<0.01, cP<0.001.